Análisis de la cuota de mercado y oportunidades de terapias antisentido y ARNi (2025-2031)
Antisense and RNAi Therapeutics Market Report Analysis
Antisense and RNAi Therapeutics Market
-
CAGR (2025 - 2031)7.50% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Alnylam Pharmaceuticals
- Benitec Biopharma Ltd.
- Quark Pharmaceuticals
- Ionis Pharmaceuticals
- Astellas Pharma Inc
- Marina Biosciences
- Sanofi S
- Dicerna Pharmaceuticals
- Tekmira Pharmaceuticals
Regional Overview
- Norteamérica
- Europa
- Asia-Pacífico
- América del Sur y Central
- Oriente Medio y África
Market Segmentation
By Tipo
- ARN de interferencia
- ARN antisentido
By Vía de administración
- administración pulmonar
- inyecciones intravenosas
- intradérmica
- intraperitoneal
- tópica
- otras
By Aplicación
- Enfermedades infecciosas
- enfermedades cardiovasculares
- cáncer
- trastornos neurológicos
- otros
By Geografía
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Oriente Medio y África
Get Free Sample For